Skip to main content
OpenTrials

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Active, Not Recruiting

Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)

NCT04954859

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site San Jose, California, United States
  • GSK Investigational Site Colorado Springs, Colorado, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 163 locations
View Trial Details
Active, Not Recruiting

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

NCT02932150

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Rady Childrens Hospital San Diego, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)

NCT06829329

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • The Second Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
  • The Third People's Hospital of Zhenjiang Zhenjiang, Jiangsu, China
  • The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

NCT06550128

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
  • The third People's Hospital of Zhenjiang Zhenjiang, Jiangsu, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, China
  • The Second Affiliated Hospital of Chongqing Medical University Chongqing, China
View Trial Details
Active, Not Recruiting

Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)

NCT07246889

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • AusperBio Investigational Site Hefei, Anhui, China
  • AusperBio Investigational Site Beijing, Beijing Municipality, China
  • AusperBio Investigational Site Chongqing, Chongqing Municipality, China
  • AusperBio Investigational Site Fuzhou, Fujian, China
View all 28 locations
View Trial Details

Related conditions